0 followers
Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.
Thomas Gad
Immunovant
6 followers
Bolt Biotherapeutics
6 followers
C4 Therapeutics
5 followers
Summit Therapeutics
5 followers
Owkin
4 followers
Stemline Therapeutics
3 followers
AnaptysBio
3 followers
Rigel Pharmaceuticals
3 followers
Arcturus Therapeutics
2 followers
Arcutis Biotherapeutics
2 followers
ACROBiosystems
2 followers
Explore companies